Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Press release submission
| Jan 16, 2019
JANSSEN: Announces European Commission approval of ERLEADA®(apalutamide) for non-metastatic castration-resistant prostate cancer patients who are at high risk of developing metastatic disease
Press release submission
| Jan 5, 2019
EPIZYME, INC.: Announces Registration Path for Tazemetostat for Follicular Lymphoma and Provides Pipeline Updates and 2019 Guidance
Press release submission
| Dec 13, 2018
SELECT MEDICAL: Bolsters Commitment To Patient Safety And Quality
Press release submission
| Dec 6, 2018
JANSSEN: DARZALEX® (daratumumab) Combination Regimens Show Positive Results for Newly Diagnosed and Relapsed Patients with Multiple Myeloma
Press release submission
| Nov 26, 2018
ABBVIE: Receives US FDA Accelerated Approval for VENCLEXTA® (venetoclax) for Treatment of Newly-Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy
Press release submission
| Nov 7, 2018
PARTNER THERAPEUTICS: Receives FDA Orphan Drug Designation for Leukine® for the Treatment of Pulmonary Alveolar Proteinosis
Harmony Valdoz
| Aug 28, 2018
Pharmaceutical industry group backs proposal to share drug savings with Medicare beneficiaries
Press release submission
| Jul 31, 2018
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK: Massachusetts Joins Ranks of States Preventing Tobacco Sales to Youth Under 21, Becomes First State to Pass Tobacco Sale Ban
Trending
+
Pharmaceuticals
Patient Daily
| Apr 30, 2024
Unruly Sports Parents’ Effect on Children’s Mental Health
+
Pharmaceuticals
Patient Daily
| May 1, 2024
Asthma Awareness Month: American Lung Association Focuses on Addressing Challenges of Extreme Heat and Asthma
+
Technology/Innovation
Patient Daily
| Apr 30, 2024
Co-founder of Binance: Medical research is currently 'too profit driven'
+
Pharmaceuticals
Patient Daily
| May 2, 2024
South Florida Turns Turquoise for Lung Cancer Action Week
« First
«
…
12
13
14
15
16
17
18
…
»
Last »